Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
dc.authorscopusid | 57218294026 | |
dc.authorscopusid | 6602104436 | |
dc.contributor.author | Boyacıoğlu, Özge | |
dc.contributor.author | Korkusuz,P. | |
dc.contributor.other | Basic Sciences | |
dc.date.accessioned | 2024-07-05T15:50:19Z | |
dc.date.available | 2024-07-05T15:50:19Z | |
dc.date.issued | 2023 | |
dc.department | Atılım University | en_US |
dc.department-temp | Boyacıoğlu Ö., Department of Bioengineering, Graduate School of Science and Engineering, Hacettepe University, Ankara, Turkey, Department of Medical Biochemistry, Faculty of Medicine, Atılım University, Ankara, Turkey; Korkusuz P., Department of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara, Turkey | en_US |
dc.description.abstract | Endogenous and exogenous cannabinoids modulate many physiological and pathological processes by binding classical cannabinoid receptors 1 (CB1) or 2 (CB2) or non-cannabinoid receptors. Cannabinoids are known to exert antiproliferative, apoptotic, anti-migratory and anti-invasive effect on cancer cells by inducing or inhibiting various signaling cascades. In this chapter, we specifically emphasize the latest research works about the alterations in endocannabinoid system (ECS) components in malignancies and cancer cell proliferation, migration, invasion, angiogenesis, autophagy, and death by cannabinoid administration, emphasizing their mechanism of action, and give a future perspective for clinical use. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG. | en_US |
dc.identifier.citation | 2 | |
dc.identifier.doi | 10.1007/5584_2022_748 | |
dc.identifier.endpage | 169 | en_US |
dc.identifier.issn | 0065-2598 | |
dc.identifier.pmid | PubMed:36396926 | |
dc.identifier.scopus | 2-s2.0-85151042811 | |
dc.identifier.startpage | 145 | en_US |
dc.identifier.uri | https://doi.org/10.1007/5584_2022_748 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14411/4131 | |
dc.identifier.volume | 1410 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Advances in Experimental Medicine and Biology | en_US |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Autophagy | en_US |
dc.subject | Cancer | en_US |
dc.subject | Cannabinoid receptors | en_US |
dc.subject | Cannabinoids | en_US |
dc.subject | Cell cycle | en_US |
dc.subject | Invasion | en_US |
dc.subject | Migration | en_US |
dc.subject | Proliferation | en_US |
dc.title | Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells | en_US |
dc.type | Book Part | en_US |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | eec3b848-b659-4208-b834-1a47762239d1 | |
relation.isAuthorOfPublication.latestForDiscovery | eec3b848-b659-4208-b834-1a47762239d1 | |
relation.isOrgUnitOfPublication | c6d3b3b7-f103-4779-9789-92b2e2420f2d | |
relation.isOrgUnitOfPublication.latestForDiscovery | c6d3b3b7-f103-4779-9789-92b2e2420f2d |